Addex Therapeutics's total assets for Q4 2024 were CHF10.68M, a decrease of -12.24% from the previous quarter. ADXN total liabilities were CHF1.00M for the fiscal quarter, a -9.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.